The Global Membranous Nephropathy Market is expected to grow at a CAGR of 3.5% during the forecast period 2018-2023.
Membranous nephropathy is a kidney disorder. It is an autoimmune disorder which can occur by itself or in conjunction with several other diseases. Membranous nephropathy is one of the most common causes of the nephrotic syndrome. Membranous nephropathy can be caused due to various factors such as any autoimmune disease, use of certain medications such as nonsteroidal anti-inflammatory drugs, and exposure to certain infection such as hepatitis B, hepatitis C, and syphilis.
The global membranous nephropathy market is majorly driven by the growing prevalence of kidney disorders, rising older population leading to rise in the patient population, the rise in hepatitis affected infections, and growing mass young population inclined towards a sedentary lifestyle. Additionally, government funding’s, rising demand for novel treatment and market players offering advanced products are likely to drive the market.
Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/5759 .
According to the United Nations, in 2017 approximately over 962 million population were aged over 60 and above globally. United Nations has also estimated that by 2050, the number of older population is likely to reach 425 million. Additionally, according to WHO, around 71 million people are affected with hepatitis C globally. This rising aging population and rising hepatitis cases are likely to propel the growth of the global membranous nephropathy market. Factors that are likely to hamper the growth of the market are the lack of awareness regarding treatment.
Some of the key players in the membranous nephropathy market are Abbvie, Inc., Allergan Plc., Amgen Inc., Astrazeneca Plc, F. Hoffmann-La Roche Ltd, and FibroGen, Pfizer Inc., among others.
The Americas dominates the global membranous nephropathy market owing to the rising aging population and increasing rate of kidney disorders. Additionally, rising patient population rates along with increasing healthcare expenditure are likely to enhance the growth of membranous nephropathy in the North American region. Similarly, according to the National Kidney Foundation, in 2015 the U.S. is expected to spend around USD 48 million for the treatment of chronic kidney diseases.
Europe accounts for the second largest market due to increasing aging mass and increasing obesity rates. Additionally, improving government support and increasing healthcare infrastructure along with rising demand for technologically advanced treatment is driving the growth of the membranous nephropathy market in Europe. For instance, Eurostat estimated that over 19.2% of the population in Europe was aged 65 and above. Additionally, according to NHS, around 215,000 people have hepatitis C in the U.K. These rising rates in infection affected population is likely to drive the growth of the membranous nephropathy market.
Asia Pacific is the fastest growing market for membranous nephropathy whose growth is attributed to the rising population, which in turn increases the overall patient population and rising population affected by genetic disorders. Additionally, increasing healthcare expenditure and demand for new and innovative treatment options along with the rise in the standard of living are likely to drive the growth of the market. India and China are the foremost contributors to the market growth due to the growing demand for advanced treatments and rising rapid development of healthcare infrastructure in these regions.
Grab Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/5759 .
On the other hand, the Middle East and Africa is expected to witness a limited growth due to limited access to healthcare and lack of awareness among individuals. In the Middle East, the growth of the market is driven by the increasing introduction of new and innovative products for diagnostic and treatment of various chronic diseases.
1 Report Prologue
2 Market Introduction
2.2 Scope of Study
2.2.1 Research Objective
3 Research Methodology
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4 Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5 Market Factor Analysis
Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/5759 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312